Pfizer is a Buy at low valuation but faces a 2030 patent cliff, COVID sales declines, and LOE risks. Click here to read an ...
AutoCanada remains a Hold as operational weakness offsets recent financial improvements, and valuation appears fair given ...
GPIX has outperformed SPYI by 10.25 PP since inception, delivering an attractive 8% yield and strong total returns. The ETF ...
Alphabet, Mettler-Toledo International and Apple were among the portfolio’s top contributors for the quarter, while Oracle, ...
General Motors ( GM) CEO Mary Barra still sees electric vehicles as "the endgame" and expects wider adoption in the U.S. once ...
Mar Vista’s U.S. Quality Premier strategy returned +1.80% net-of-fees in the fourth quarter of 2025. Read more here.
Imperial Petroleum boasts a debt-free balance sheet, strong cash flow, and significant fleet expansion. Read why IMPP stock ...
InfraCap MLP ETF maintains a buy rating despite underperforming the S&P 500 by over 20 percentage points in the past year.
The US sovereign wealth fund (SWF) announced in early 2025 is not a symbolic policy experiment or a passive reserve vehicle.
The Blue Tower Global Value strategy composite gained 13.15% net in Q4 (13.46% gross), bringing the total net gain for 2025 ...
Review Fidelity Fundamental Large Cap Growth ETF (FFLG): active large-cap growth, factor/GARP tilt, returns vs IVV/QQQM, ...
During the quarter, we initiated new investments in Taiwan Semiconductor and Netflix, while we exited our positions in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results